NASDAQ · STOCK
Baxter International
$26.15
52W $15.73 – $30.00
50/100
$13.51B
-12.8
0.61
Is BAX Bullish or Bearish?
Mixed.
Innellis AI committee rates Baxter International (BAX) Watch with a composite score of 50/100
, based on 7 analysts with 57% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +10.07 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -9.93 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.27 across 36 articles, 14d). Risk Analyst remains cautious — high leverage (debt-to-equity 1.55) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.27 across 36 articles, 14d) — News
Bear Case
- ROE of only -16.4% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 1.55 adds balance-sheet risk to the value case — Value
- Revenue declining -4.8% YoY -- this is not a growth story right now — Growth
- RSI at 84 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
- Weekly RSI at 83 -- overbought on the larger timeframe too — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
50/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 89%
of 93 Healthcare peers
Value Analyst
bearish
40
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− ROE of only -16.4% -- cheap may mean cheap for a reason
Growth Analyst
neutral
50
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -4.8% YoY -- this is not a growth story right now
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 84 is in overbought territory
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.55) amplifies downside in a stress scenario
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 36 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 50.3 to 49.9.
- Committee agreement increased notably from 43% to 57%.
- New bearish signals: 5 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 2 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: +2 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
74.9
Overbought
MACD Histogram
0.344
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$21.59
Resistance
$32.00
Bollinger %B
1.05
Above Upper Band
Price vs Moving Averages
EMA 9
$24.35
Above
EMA 21
$23.15
Above
EMA 50
$21.62
Above
EMA 200
$21.08
Above
Fundamental Analysis
Valuation
97
Growth
69
Profitability
0
Financial Health
71
Cash Flow
36
Valuation
P/E Ratio
-12.8×
P/B Ratio
2.18×
PEG Ratio
0.16
Dividend Yield
0.01%
52W High
$30.00
52W Low
$15.73
Quality & Growth
ROE
-15.6%
ROA
-4.8%
Gross Margin
30.1%
Operating Margin
-2.4%
Revenue Growth YoY
—
Debt / Equity
1.56
AI Fundamental Assessment
P/E ratio of -12.8 (inexpensive relative to a 15-40x range); Price-to-book of 2.2x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -0.2%; Return on assets of -0.0%; Net margin of -0.1%; Gross margin of 0.3%; Current ratio of 1.95 (healthy short-term liquidity); Debt-to-equity of 1.56; Free cash flow margin of 0.4% (thin cash generation); Free cash flow per share is positive (0.61); Most recent quarter beat estimates by 51.5%; 2 consecutive earnings beats; EPS growth accelerating (-18.2% -> +55.6% QoQ); Average YoY EPS growth of -5.1%; Analyst estimates falling over recent quarters
Get the Full BAX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →